Belpointe Asset Management »

Sangamo Biosciences shares owned by Belpointe Asset Management

Quarter-by-quarter ownership of Sangamo Biosciences (SGMO) shares owned by Belpointe Asset Management from 13F filings

Historical chart of Belpointe Asset Management investment in Sangamo Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Sangamo Biosciences held by Belpointe Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sangamo Biosciences by Belpointe Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $17k 68k 0.25
2023-03-31 $1.8k 1.0k 1.76
2022-12-31 $3.1k 1.0k 3.14

More positions owned by Belpointe Asset Management

Spdr S&p 500 Etf Etf (SPY)
Invesco QQQ Trust Etf (QQQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Collaborative Investmnt Ser Etf (PLGI)
Anydrus Advantage Etf Etf (NDOW)
Schwab U.S. Large-Cap Growth ETF Etf (SCHG)
Nelson Select Etf (NELS)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Rareview Total Return Bond Etf Etf (RTRE)
Schwab Strategic Tr Etf (SCHX)
Vanguard S&P 500 ETF Etf (VOO)
Sch Fnd Us Lg Etf schwb fdt us lg (FNDX)
Ishares Tr Etf (IVV)

View all positions for Belpointe Asset Management

Top funds holding Sangamo Biosciences

Armistice Capital
Vanguard Capital Management
Vanguard Group
Renaissance Technologies
Two Sigma Investments
Balyasny Asset Management
Geode Capital Management
BlackRock
Susquehanna International
UBS Group
Vanguard Fiduciary Trust
Jacobs Levy Equity Management
Bank of America Corporation
Charles Schwab Investment Management
Luminus Management

View all funds holding Sangamo Biosciences